Preclinical Data Readout for MDL-001 - Direct-Acting, Broad-Spectrum Antiviral

Preclinical Data Readout for MDL-001

Platform

Programs

Pipeline

Newsroom

About

Investors

Investors

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Events

Jan 16, 2020

Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships and Investor Relations

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Exploring the Digital Transformation of Healthcare
Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships and Investor Relations

Related Content

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

May 14, 2026

Model Medicines to Present End-to-End AI Drug Discovery Platform at Fierce Biotech Week 2026 in Boston

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

May 14, 2026

Model Medicines to Present End-to-End AI Drug Discovery Platform at Fierce Biotech Week 2026 in Boston

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego

Model Medicines presentation on end-to-end AI drug discovery at Fierce Biotech Week 2026

Events

May 14, 2026

Model Medicines to Present End-to-End AI Drug Discovery Platform at Fierce Biotech Week 2026 in Boston

Platform

GALILEO™

Programs

RdRp Thumb 1

BRD4

Pipeline

Pipeline

Lead Assets

MDL-001

MDL-4102

Investors

Investor Relations

Company

Model Medicines

Newsroom

Contact

© 2026 Model Medicines. All Rights Reserved.

Platform

GALILEO™

Programs

RdRp Thumb 1

BRD4

Pipeline

Pipeline

Lead Assets

MDL-001

MDL-4102

Investors

Investor Relations

Company

Model Medicines

Newsroom

Contact

© 2026 Model Medicines. All Rights Reserved.

Platform

GALILEO™

Programs

RdRp Thumb 1

BRD4

Pipeline

Pipeline

Lead Assets

MDL-001

MDL-4102

Investors

Investor Relations

Company

Model Medicines

Newsroom

Contact

© 2026 Model Medicines. All Rights Reserved.